Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: A 3-month randomised, double-blind, multicentre, noninferiority trial

Drugs

Volumn 67, Issue 3, 2007, Pages 393-405

  Ruzyllo, Witold ^a   Tendera, Michal ^b   Ford, Ian ^c   Fox, Kim M ^d  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; IVABRADINE; NITRATE;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EXERCISE TOLERANCE; FEMALE; HEART INFARCTION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL EDEMA; RANDOMIZED CONTROLLED TRIAL; SINUS BRADYCARDIA; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; VISUAL DISORDER;

AGED; AMLODIPINE; ANGINA PECTORIS; BENZAZEPINES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOTONIC AGENTS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITRATES;

ANGINA;

EID: 33947233212     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200767030-00005     Document Type: Article

References (28)

1. Bucchi A, Baruscotti M, DiFrancesco D. Current-dependent block of rabbit sino-atrial node If channels by ivabradine. J Gen Physiol 2002; 120: 1-13
2. Simon L, Ghaleh B, Puybasset L, et al. Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 1995; 275: 659-66
3. Ragueneau I, Laveille C, Jochemsen R, et al. Pharmacokinetic pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers. Clin Pharmacol Ther 1998, 64: 192-203
4. Vilaine JP, Bidouard JP, Lesage L, et al. Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs. J Cardiovasc Pharmacol 2003; 42: 688-96
5. Borer JS, Fox K, Jaillon P, et al., for the Ivabradine Investigators Group. Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blind, multicentred, placebo-controlled trial. Circulation 2003; 107: 817-23
6. Tardif JC, Ford I, Tendera M, et al. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005 Dec; 26 (23): 2529-36
7. ACC/AHA 2002. Guideline update for the management of patients with chronic stable angina [online]. Available from URL: http://www.acc.org/clinical/ guidelines/stable [Accessed 2003 Aug 22]
8. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on the clinical investigation of anti-anginal medicinal products in stable angina pectoris. London: European Agency for the Evaluation of Medicinal Products, 1996. CPMP/EWP/234/95
9. Morganroth J. Proarrhythmic effects of antiarrhythmic drugs: evolving concepts. Am Heart J 1992; 123: 1137-9
10. Pepine CJ, Abrams J, Marks RG, et al. Characteristics of a contemporary population with angina pectoris. TIDES investigators. Am J Cardiol 1994; 74: 226-31
11. Bois P, Bescond J, Renaudon B, et al. Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol 1996; 118: 1051-7
12. Kannel WB, Kannel C, Paffenbarger RS, et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-94
13. Diaz A, Bourassa MG, Guertin MC, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 967-74
14. Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J 1999; 1 Suppl.: H64-9
15. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Guidelines on the management of stable angina pectoris. Eur Heart J 2006; 27: 1341-81
16. Thackray S, Ghosh J, Wright G, et al. The effect of altering heart rate on ventricular function in patients with heart failure trated with β-blockers. Am Heart J 2006; 152 (4): 713.e9-13
17. Cucherat M. Relationship between heart rate lowering and benefits on cardiac and sudden death observed with beta-blockers in post MI patients: a meta-regression of randomized clinical trials. Eur Heart J 2006; 27 (Abstract Suppl.): 590
18. Asirvatham S, Sebastian C, Thadani U. Choosing the most appropriate treatment for stable angina: safety considerations. Drug Saf 1998; 19: 23-44
19. Fox KM, Jespersen CM, Ferrari R, et al. How European cardiologists perceive the role of calcium antagonists in the treatment of stable angina. Eur Heart J 1997; 18 Suppl. A: A113-6
20. Ezekowitz MD, Hossack K, Mehta JL, et al. Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J 1995; 129: 527-35
21. Pehrsson SK, Ringqvist I, Ekdahl S, et al. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris. Clin Cardiol 2000; 23: 763-70
22. Hjalmarson A, Gilpin EA, Kjekshus J, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990; 65: 547-53
23. Hjalmarson A. Significance of reduction in heart rate in cardiovascular disease. Clin Cardiol 1998; 21 (12 Suppl.): II3-7
24. Guth BD, Heusch G, Seitelberger R, et al. Mechanism of beneficial effect of β-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 1987; 60: 738-46
25. Demontis GC, Moroni A, Gravante B, et al. Functional characterisation and subcellular localisation of HCN1 channels in rabbit retinal rod photoreceptors. J Physiol 2002; 542 (Pt 1): 89-97
26. Demontis GC, Gargini C, Paoli GT, et al. Ivabradine inhibits the hyperpolarization-activated inward current (Ih) in mouse rod photoreceptors. Documenta Ophthalmol 2006; 112: 102-3
27. Gargini C, Demontis GC, Della Santina L, et al. Effects of acute and chronic ivabradine administration on retinal function and morphology in pigmented rats. Documenta Ophthalmol 2006; 112 (133): S2-16
28. Fox K, Ferrari R, Tendera M, et al. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study. Am Heart J 2006; 152: 860-6